Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00180544 · ClinicalTrials.gov registry record · Phase 3
Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease
A Phase 3 study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- Phase 3
- Development phase
- 167
- Enrollment target
NCT00180544: Clinical Trial Phase 3 study, sponsored by Abbott Medical Devices.
NCT00180544 is a Phase 3 study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 167 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00180544, a Phase 3 study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 167 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the RX HERCULINK 14 Peripheral Stent System in treating atherosclerotic renal artery stenosis.
Interventions
- DEVICE Stenting: Renal Artery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2000-07 |
| Est. Completion | 2004-08 |
| Phase | Phase 3 |
Why NCT00180544 stopped before completion
NCT00180544 is an interventional study that assigns participants to a tested intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Stenting: Renal Artery is the first listed.
NCT00180544 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00180544 about?
NCT00180544 is a clinical study titled "Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease". The purpose of this study is to evaluate the safety and effectiveness of the RX HERCULINK 14 Peripheral Stent System in treating atherosclerotic renal artery stenosis.
What is the current status of trial NCT00180544?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 167 participants. The study started on 2000-07. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00180544?
The interventions under investigation include: Stenting: Renal Artery (DEVICE).
Who is sponsoring clinical trial NCT00180544?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00180544's enrollment target sits among peer trials
167 1463rd of 2000 higher than 538 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia